![](/img/cover-not-exists.png)
Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation
Siddhartha Ganguly, Clint L. Divine, Omar S. Aljitawi, Sunil Abhyankar, Joseph P. McGuirk, Leland GravesVolume:
26
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1399-0012.2011.01527.x
File:
PDF, 284 KB
english, 2012